Summary of Product Characteristics
last updated on the eMC:
01/06/2011
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 01/06/2011 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 21-May-2011 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
Section 4.4 (Special warnings and precautions for use), Section 4.5 (Interaction with other medicinal products and other forms of interaction), Section 4.6 (Pregnancy and lactation) and Section 4.8 (Undesirable effects) have been updated
|
|
Updated on 21/01/2011 and displayed until 01/06/2011
|
Reasons for adding or updating:
|
-
New individual SPC (was previously included in combined SPC)
|
| Date of revision of text on the SPC: |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|